Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,130,363
-$116,580 QoQ
Shares Held
8,947
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,019
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. GILD ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
|
2,801 | $711,369 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130,363 | 8,947 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,246,943 | 8,947 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $1,306,812 | 10,647 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,210,344 | 10,904 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,208,926 | 10,904 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,255,408 | 11,204 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,422,867 | 15,404 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,796,607 | 21,429 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,796,474 | 40,759 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,713,033 | 37,038 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,431,110 | 30,010 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,591,799 | 34,585 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,880,799 | 37,379 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,228,528 | 38,912 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,343,428 | 38,945 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $3,143,784 | 50,961 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,152,186 | 50,998 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,056,383 | 51,411 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,719,519 | 51,226 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,590,010 | 51,396 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,611,293 | 52,444 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,382,604 | 52,338 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,006,241 | 34,436 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $3,252,389 | 51,470 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,849,308 | 50,030 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,773,511 | 50,475 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||